Hyperinsulinemia directly promotes endometrial cell proliferation and indirectly increases risk by reducing sex hormone-binding globulin (SHBG), which increases the bioavailability of estrogens [53,54]. The gene discussed is SHBG; the disease is hyperinsulinism.